Pediatric Flu Vaccine – 2025-2026
Award Notice Posted
- Solicitation number
- 75D301-25-D-20400
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- to Astrazeneca Pharmaceuticals LP
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D301-25-D-20400 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Atlanta, Georgia 30341, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) Office of Acquisition Services has awarded a contract (75D301-25-D-20400) to AstraZeneca Pharmaceuticals LP for pediatric flu vaccines for the 2025-2026 season. The contract, valued at $51,900,000, was awarded on December 30, 2024, without a specific set-aside designation. This civilian agency procurement appears to be for the procurement of influenza vaccines targeted specifically for pediatric populations, securing immunization supplies for the upcoming flu season.
Notice text
Awarded contract 75D301-25-D-20400 to ASTRAZENECA PHARMACEUTICALS LP for 51900000.00 on 2024-12-30.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Pediatric Flu Vaccine – 2025-2026 | Award Notice | |
| Pediatric Flu Vaccine – 2025-2026 | Award Notice | |
| Pediatric Flu Vaccine – 2025-2026 | Award Notice | |
| This notice | Award Notice | |
| Pediatric Flu Vaccine – 2025-2026 | Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity